查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511908

精准医疗市场规模、份额、趋势分析报告：按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics, Therapeutics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

精准医疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球精准医疗市场规模将达到2,492.4亿美元，2024年至2030年复合年增长率为16.3%。

引入具有成本效益的基因组和分子生物学测试方法、癌症和罕见疾病盛行率的增加以及巨量资料在精准医疗中的使用不断增加等趋势是推动市场成长的一些关键因素。

人类基因组计划引入了令人兴奋的最尖端科技，例如全基因组序列测定和靶向序列测定。研究人员使用这些技术来研究基因组并创造治疗各种疾病的个人化疗法。如今，世界范围内肿瘤学、免疫学和神经学等领域的疾病盛行率正在迅速增加。

研究人员、医疗保健专业人员以及大型製药和生物技术公司正在共同努力，为患者健康发现新的治疗方法选择。许多治疗方法和药物目前正在进行临床试验以治疗各种类型的癌症。此外，研究人员有兴趣在癌症以外的疾病领域开发精准医学和诊断方法。

除了治疗之外，诊断领域近年来也经历了快速成长。次世代定序（NGS）、生物标记、伴同性诊断和深奥测试的使用有可能改变和影响药物处方模式。个人化药物很可能在未来20年内取得巨大成功，并有能力治疗和治癒少数以前不可能的疾病。

政府和监管机构的参与对该行业的发展发挥着至关重要的作用。 2015年，时美国政府宣布推出精准医疗计画。隔年，中国推出了中国精准医疗计画。这是一项为期15年的计划，旨在使该国成为精准治疗发展的领导者。

目前，生物技术和製药公司改进产品线中超过 40% 的药物都含有生物标记。该简报还建议，多家生物製药公司在过去五年中已经建立了合作和合资企业，预计未来几年将继续下去。因此，诊断和治疗精准医学市场潜力巨大，并正在迅速转变为患者照护的基本领域。

精准医疗市场报告亮点

  • 治疗领域将在 2023 年引领市场，预计在预测期内复合年增长率为 15.8%。
  • 至2023年，医院业将以60.0%的销售份额引领市场。医院凭藉其完善的基础设施和接触不同患者群体的能力，为个人化医疗提供了理想的环境。
  • 2023年北美精准医疗市场占比53.62%。根据 2022 年 PMC 报告，自 2014 年以来，个人化医疗占 FDA核准的药物的四分之一以上。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章精准医疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 市场机会分析
  • 精准医疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析
    • 定量分析（设备）

第四章精准医疗市场：应用预估与趋势分析

  • 全球精准医疗市场：应用仪表板
  • 全球精准医疗市场：应用变迁分析
  • 全球精准医疗市场：按应用和收益
  • 诊断
  • 治疗

第五章精准医疗市场：最终用途估计与趋势分析

  • 全球精准医学市场：最终用途仪表板
  • 全球精准医疗市场：最终用途变异分析
  • 全球精准医疗市场：依最终用途、按收益
  • 居家照护
  • 医院
  • 临床实验室
  • 其他的

第六章 精准医疗市场：依类别、应用、最终用途和调查方法进行区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Janssen Global Services, LLC
    • Illumina, Inc.
    • Quest Diagnostics Incorporated
    • 23andMe, Inc.
    • NeoDiagnostix
    • Myriad Genetics
    • Medtronic
    • GE Healthcare
    • Abbott
    • QIAGEN
Product Code: GVR-2-68038-612-7

Precision Medicine Market Growth & Trends:

The global precision medicine market size is expected to reach USD 249.24 billion by 2030 growing at a CAGR of 16.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights:

  • The therapeutics segment led the market in 2023 and is expected to grow at a CAGR of 15.8% over the forecast period.
  • The hospitals segment led the market with a revenue share of 60.0% in 2023. Hospitals provide the ideal setting for personalized medicine due to their comprehensive infrastructure and access to diverse patient populations.
  • The North America precision medicine market accounted for 53.62% share in 2023. PMC report published in 2022 notes that personalized medicines now account for more than one in four drugs approved by the FDA since 2014.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application and End-use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in next-generation sequencing
      • 3.2.1.2. Expanding portfolio of companion/associated diagnostics
      • 3.2.1.3. Increasing prevalence of cancer & usage of biomarkers for precision medicine cancer therapy
      • 3.2.1.4. Growing healthcare expenditure triggering development of effective precision medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of nonvalue-based precision medicine diagnostics reimbursement policy
      • 3.2.2.2. Lack of proper intellectual property regulations for precision medical technologies
      • 3.2.2.3. Nonstructural development of biomarkers
  • 3.3. Market opportunity analysis
      • 3.3.1.1. Advancements in genomic technologies
  • 3.4. Precision Medicine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Pricing Analysis
    • 3.4.4. Volume Analysis (Instruments)

Chapter 4. Precision Medicine Market: Application Estimates & Trend Analysis

  • 4.1. Global Precision Medicine Market: Application Dashboard
  • 4.2. Global Precision Medicine Market: Application Movement Analysis
  • 4.3. Global Precision Medicine Market by Application, Revenue
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Direct to Consumer Tests
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Esoteric Tests
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Pharmaceuticals
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Oncology
      • 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. Respiratory Disease
      • 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Skin Diseases
      • 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.5. CNS Disorders
      • 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.6. Immunology
      • 4.5.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.7. Genetic Diseases
      • 4.5.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.8. Others
      • 4.5.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Medical Devices
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine Market: End-use Estimates & Trend Analysis

  • 5.1. Global Precision Medicine Market: End-use Dashboard
  • 5.2. Global Precision Medicine Market: End-use Movement Analysis
  • 5.3. Global Precision Medicine Market by End-use, Revenue
  • 5.4. Home care
    • 5.4.1. Home care market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis by Category, Application, End-use and Methodology

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. F. Hoffmann-La Roche Ltd
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers AG
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Janssen Global Services, LLC
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Illumina, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Quest Diagnostics Incorporated
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. 23andMe, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. NeoDiagnostix
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Myriad Genetics
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Medtronic
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. GE Healthcare
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Abbott
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. QIAGEN
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 10 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 17 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 France precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 19 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 21 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 23 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 27 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 29 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 34 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 38 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 47 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 54 MEA precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in Asia Pacific
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Precision medicine market: market outlook
  • Fig. 14 Precision medicine competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Precision medicine market driver impact
  • Fig. 18 Precision medicine market restraint impact
  • Fig. 19 Precision medicine market: Application movement analysis
  • Fig. 20 Precision medicine market: Application outlook and key takeaways
  • Fig. 21 Diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Genetic tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Direct to Consumer Tests estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Esoteric Tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Respiratory Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Skin Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 CNS Disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Immunology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Genetic Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Medical Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Precision medicine market: End-use movement analysis
  • Fig. 38 Precision medicine market: End-use outlook and key takeaways
  • Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Clinical laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Global precision medicine market: Regional movement analysis
  • Fig. 44 Global precision medicine market: Regional outlook and key takeaways
  • Fig. 45 Global precision medicine market share and leading players
  • Fig. 46 North America, by country
  • Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. key country dynamics
  • Fig. 49 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Canada key country dynamics
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico key country dynamics
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UK key country dynamics
  • Fig. 56 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Germany key country dynamics
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 France key country dynamics
  • Fig. 60 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Italy key country dynamics
  • Fig. 62 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Spain key country dynamics
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark key country dynamics
  • Fig. 66 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Japan key country dynamics
  • Fig. 75 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 India key country dynamics
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Australia key country dynamics
  • Fig. 83 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil key country dynamics
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina key country dynamics
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 South Africa key country dynamics
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Saudi Arabia key country dynamics
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 UAE key country dynamics
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait key country dynamics
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Market share of key market players- Precision medicine market